Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

Masimo (NASDAQ:MASI – Get Free Report) had its price objective upped by equities researchers at Piper Sandler from $210.00 to $215.00 in a report released on Wednesday,Benzinga reports. The brokerage ...

Masimo (MASI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Wells Fargo raised the firm’s price target on Masimo (MASI) to $205 from $193 and keeps an Overweight rating on the shares. The firm is ...

Sigma Planning Corp lifted its stake in Masimo Co. (NASDAQ:MASI – Free Report) by 21.7% during the fourth quarter, Holdings ...

Masimo says strategic realignment efforts near the end of last year increased the digital health pioneer's earnings power.

Q4 2024 Earnings Call Transcript February 25, 2025 Masimo Corporation beats earnings expectations. Reported EPS is $1.67, ...

Piper Sandler analyst Jason Bednar raised the firm’s price target on Masimo (MASI) to $215 from $210 and keeps an Overweight rating on the ...

Shares of Health Care sector company Masimo moved 10.5% today, and are now trading at a price of $187.31. The Large-Cap stock ...

Masimo Corporation’s MASI share price has surged by 12.35%, which has investors questioning if this is right time to sell.

Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare ...

Medical tech company Masimo (NASDAQ:MASI) reported in Q4 CY2024, with sales up 9.4% year on year to $600.7 million. Its ...